National Medical Research Center for Cardiology, 3rd Cherepkovskaya St., 15a, Moscow, 121552, Russian Federation.
National Medical Research Center for Cardiology, 3rd Cherepkovskaya St., 15a, Moscow, 121552, Russian Federation; Faculty of Fundamental Medicine, Lomonosov Moscow State University, Lomonosovsky Av., 27/1, Moscow, 119192, Russian Federation.
Biochimie. 2020 Jan;168:83-91. doi: 10.1016/j.biochi.2019.10.010. Epub 2019 Oct 24.
Myosin activation contributes to the contractile forces that induce disturbances in the vascular endothelial integrity and promote protein-rich edema of the underlying tissues. Myosin light chain kinase (MLCK) and Rho-associated protein kinase (ROCK) have been reported to phosphorylate myosin regulatory light chains (RLC) for myosin activation. However, the relative contribution and roles of these kinases are debatable and not understood in very detail. In this study, using a combinational inhibitory analysis of MLCK, ROCK, and their antagonist, myosin light chain phosphatase (MLCP), we show that the MLCK-dependent RLC mono-(Ser19)phosphorylation (P-RLC) is sufficient to induce the FITC-dextran hyperpermeability in EA.hy926 endothelial cells (EC) in response to thrombin. However, MLCK relies on the ROCK assistance that attenuates MLCP activity. On the other hand, MLCK supplies P-RLC myosin as an intermediate substrate to ROCK thus adding to a faster accumulation of di-(Thr18/Ser19)phosphorylated RLC (PP-RLC) by the latter kinase. ROCK also produces P-RLC but is solely responsible for the thrombin-induced PP-RLC generation in EA.hy926 EC and other cell types. Still, as a direct myosin activator, ROCK contributes less to endothelial hyperpermeability than MLCK. Our findings are consistent with a concerted complementary mutual interplay between ROCK and MLCK to activate endothelial myosin and elicit the thrombin-mediated EC barrier dysfunction.
肌球蛋白的激活有助于产生收缩力,导致血管内皮完整性紊乱,并促进下方组织富含蛋白质的水肿。肌球蛋白轻链激酶(MLCK)和 Rho 相关蛋白激酶(ROCK)已被报道可使肌球蛋白调节轻链(RLC)磷酸化,从而激活肌球蛋白。然而,这些激酶的相对贡献和作用仍存在争议,并且了解得还不够详细。在这项研究中,我们使用 MLCK、ROCK 及其拮抗剂肌球蛋白轻链磷酸酶(MLCP)的组合抑制分析表明,MLCK 依赖性 RLC 单(Ser19)磷酸化(P-RLC)足以诱导凝血酶刺激 EA.hy926 内皮细胞(EC)中 FITC-葡聚糖的高通透性。然而,MLCK 依赖于 ROCK 的辅助作用,减弱了 MLCP 的活性。另一方面,MLCK 将 P-RLC 肌球蛋白作为中间底物供应给 ROCK,从而增加后者激酶更快地积累二(Thr18/Ser19)磷酸化的 RLC(PP-RLC)。ROCK 也产生 P-RLC,但仅负责凝血酶诱导的 EA.hy926 EC 和其他细胞类型中的 PP-RLC 生成。尽管如此,作为一种直接的肌球蛋白激活剂,ROCK 对内皮通透性的促进作用不如 MLCK 大。我们的发现与 ROCK 和 MLCK 之间的协同互补相互作用一致,这种作用可激活内皮肌球蛋白并引发凝血酶介导的 EC 屏障功能障碍。